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Abstract
Introduction There is some evidence that greater consumption of fruit and vegetables decreases the risk of bladder cancer. 
The role of fruit and vegetables in bladder cancer recurrence is still unknown.
Objective The role of total fruit and vegetable intake in relation to the risk of developing bladder cancer recurrence in a 
prospective cohort study.
Methods 728 patients with non-muscle invasive bladder cancer (NMIBC), who completed self-administrated questionnaires 
on fruit and vegetable intake at time of diagnosis (over the year before diagnosis) and 1 year after diagnosis, were included. 
Hazard ratios and 95% confidence intervals were calculated by multivariable Cox regression for developing recurrent bladder 
cancer in relation to fruit and vegetable intake.
Results During 2,051 person-years of follow-up [mean (SD) follow-up 3.7 (1.5) years], 241 (33.1%) of the included 728 
NMIBC patients developed a recurrence of bladder cancer. The sum of total fruit and vegetables before diagnosis was not 
related to a first bladder cancer recurrence (HR 1.07; 95% CI 0.78–1.47, p = 0.66). No association was found between greater 
consumption of fruit and vegetables over the year before diagnosis and the risk of developing multiple recurrences of blad-
der cancer (HR 1.02; 95% CI 0.90–1.15, p = 0.78). Among the remaining 389 NMIBC patients who reported on fruit and 
vegetable intake 1 year after diagnosis, no association was found between greater consumption of fruit and vegetables and 
a first recurrence of bladder cancer (HR 0.65; 95% CI 0.42–1.01, p = 0.06) nor with multiple recurrences of bladder cancer 
(HR 1.00, 95% CI 0.85–1.18, p = 1.00). Similar results were obtained when investigating the association between total intakes 
of fruit and vegetables separately and bladder cancer recurrence.
Conclusion Results from this study did not indicate a protective role for total fruit and vegetables in the development of a 
recurrence of NMIBC.
Keywords Bladder cancer · Recurrence · Fruit · Vegetables · Prevention and control
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Introduction
Bladder cancer is the most common malignancy of the 
urinary tract and is characterized by high rates of recur-
rence [1]. Identification of modifiable risk factors, includ-
ing diet, may improve bladder cancer risk and outcome. 
The 2015 report of the WCRF Continuous Update Pro-
ject indicated that there is limited evidence that greater 
consumption of vegetables and fruit decreases the risk of 
bladder cancer [2]. Results of a large systematic review 
and dose–response meta-analysis of prospective cohort 
studies suggested that there is little evidence that sup-
ports a beneficial effect for total fruit and vegetables 
against bladder cancer [3]. Although evidence on a role 
for fruit and vegetables in bladder cancer is limited, fruit 
and vegetables contain an abundant source of minerals, 
phytochemicals, and antioxidant nutrients with potentially 
anti-carcinogenic properties. Considering the low levels of 
antioxidants in patients with bladder cancer [4], it is con-
ceivable that greater consumption of fruit and vegetables 
might result in an improved bladder cancer prognosis. A 
strategy to simply increase the amount of fruit and veg-
etables to decrease the risk of bladder cancer recurrence 
would be a compelling one. In a US study, Tang et al. 
examined the association between fruit and vegetable con-
sumption and mortality among bladder cancer patients [5]. 
An inverse association between raw broccoli intake and 
subsequent mortality among bladder cancer patients sug-
gested a role for vegetable intake in bladder cancer prog-
nosis. It should be noted that only an association with raw 
broccoli was found, not with cooked broccoli or with other 
vegetables or total fruit and vegetables. No studies as of 
yet, have made efforts to assess fruit and vegetable intake 
and reduced bladder cancer recurrence. Therefore, this is 
the first study to investigate the role of pre-diagnosis (the 
year before diagnosis) and post-diagnosis (the year after 
diagnosis) fruit and vegetable intakes in relation to the 
risk of developing bladder cancer recurrence among non-
muscle invasive bladder cancer (NMIBC) patients.
Methods
The Bladder Cancer Prognosis Programme
This study is part of the Bladder Cancer Prognosis Pro-
gramme (BCPP), a prospective cohort study in the West 
Midlands region of England. Details of the cohort have 
been published previously [6]. Briefly, during the enrol-
ment period (December 2005–October 2011), a total of 
1,550 male and female patients (age ≥ 18  years) were 
enrolled based on abnormal cystoscopic findings sugges-
tive of bladder cancer. Case report forms (CRFs) contained 
data on tumor characteristics, initial treatment, and event 
data including recurrences. Bladder cancer recurrence was 
defined as the new occurrence of a NMIBC (stage Ta, T1, 
or pTis) at the same or at a different site as the initial pri-
mary bladder tumor and excluding recurrence identified 
at the first check cystoscopy. Written informed consent 
was obtained from all participants. The study protocol 
was approved by the Nottingham Research Ethics Com-
mittee (06/MRE04/65) and registered on ClinicalTrials.
gov (NCT00553566).
Data collection
Data on social support, health-related quality of life, socio-
demographics, medical history, and health-related behaviors 
including dietary intake were collected by a trained research 
nurse using semi-structured face-to-face interviews and use 
of a questionnaire around time of diagnosis. Patients were 
asked about habitual dietary intake over the previous year 
before diagnosis. The developed version of the food-fre-
quency part of the questionnaire aims to assess the dietary 
intake, by asking the participants to report the frequency 
of consumption of approximately 16-line items over the 
last year. The frequency of fruit and vegetables asked in 
the questionnaire consisted of six categories: never or less 
than once per month, 1–3 times per month, once a week, 
2–4 times per week, 5–6 times per week, or at least once 
per day. The research nurse informed the patients that one 
portion of vegetables or fruit is about 80 g. Total fruit and 
vegetable intakes were computed as the sum of servings 
of all of groups of fruit and vegetables: citrus fruit, stone 
fruit, fleshy fruit, soft fruit, and vine fruit. Vegetable sub-
groups included: flower vegetables, leafy vegetables, stem 
vegetables, fruit vegetables, mushrooms, bulbs, and roots. 
Repeated fruit and vegetable intakes were collected through 
postal follow-up questionnaires 1–5 year after diagnosis. 
This study focuses only on fruit and vegetable intakes over 
the year before and the year after diagnosis.
Exclusion criteria
A total of 244 participants with no evidence of a bladder 
tumor (T0), patients who had a tumor that could not be 
assessed (Tx) (n = 116), had muscle invasive bladder cancer 
(MIBC) (n = 275), had radiotherapy (on suspicion of MIBC) 
(n = 8), received no transurethral resection of the primary 
bladder tumor (TURBT) (n = 16), had incomplete data on 
tumor stage, grade, size, and multiplicity (n = 53) or smok-
ing (n = 94), and missing data on fruit and vegetable intake 
before diagnosis (n = 16), were excluded from this study. 
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The final analyses for fruit and vegetable intakes and bladder 
cancer recurrence comprised 728 NMIBC patients.
Almost half of the remaining 728 patients did not com-
plete a follow-up questionnaire 1 year after diagnosis or 
developed a recurrence before completing the follow-up 
questionnaire (n = 339). A total of 389 patients remained 
for investigating the association between fruit and vegeta-
ble intake over the year after diagnosis and bladder cancer 
recurrence analyses.
Statistical analysis
A χ2 test was used to compare categorical data between 
patients with and without bladder cancer recurrences. 
Patients became at risk from the date of first TURBT and 
remained at risk until the earliest occurrence of: a recur-
rence of bladder cancer, cystectomy, death, the most recent 
surveillance cystoscopy, or study end (5-year post-TURBT). 
To identify possibly influential outliers in total fruit and veg-
etable intake, Cook’s Distance was used. Cox regression was 
used to calculate hazard ratios (HRs) and 95% confidence 
intervals (95% CI) of developing recurrent bladder cancer 
in relation to the sum of total fruit and vegetables, and total 
fruit and total vegetables separately. Additionally, associa-
tions between each subgroup of fruit (citrus/stone/fleshy/
soft/vine) and each subgroup of vegetables (flower/leaf/
stem/fruit vegetables/mushrooms/bulbs/roots) were exam-
ined with bladder cancer recurrence.
To investigate the risk of fruit and vegetables with mul-
tiple recurrences, a conditional risk set model measuring 
time from the previous bladder cancer recurrence was used. 
A conditional risk set model measuring time from the previ-
ous event was used to analyze time to multiple recurrences 
of bladder cancer. The proportional hazards assumption was 
tested using Schoenfeld residuals [7]. Patients were divided 
into three categories: the first category for total fruit intake 
corresponded to < 1 portion a day, the second category to 
1–1.5 portions a day, and the third category to > 1.5 portions 
a day. For total vegetables, the categories corresponded with 
< 1.5 portion a day, 1.5–2.5 portions a day, and > 2.5 por-
tions a day. For the sum of fruit and vegetables, the catego-
ries corresponded with < 2.5 portions a day, 2.5–4 portions 
a day, and > 4 portions a day. The association between total 
fruit and vegetable intake and bladder cancer recurrence was 
examined in both crude models and multivariate models. 
Confounders were considered a priori as factors known or 
suspected to be related with cancer recurrence and/or fruit 
and vegetables and were included in the multivariate regres-
sion models. Confounders included: age at diagnosis (con-
tinuous) [8], sex (male/female) [9], smoking status (never/
former/current smoker) [10], and tumor characteristics 
including stage (pTa/pTis/pT1), grade (1/2/3), size of larg-
est tumor (< 3 mm/≥ 3 mm), and tumor multiplicity (1/> 1) 
[11–13]. Multivariate time to multiple recurrences regres-
sion models were additionally corrected for re-resection of 
a bladder tumor as second-line treatment (yes/no). p values 
were 2-sided with a significance level of 0.05. All analyses 
were performed using Stata software version 14.
Results
During 2,051 person-years of follow-up [mean (SD) fol-
low-up 3.7 (1.5) years], 241 (33.1%) of the 728 NMIBC 
patients developed one or more recurrences of bladder can-
cer. A total of 84 (34.9%) of the 241 patients developed a 
second recurrence, 36 (14.9%) a third recurrence, 18 (7.5%) 
a fourth recurrence, 6 (2.5%) a fifth recurrence, 3 (1.2%) a 
sixth recurrence, 2 (0.8%) a seventh recurrence, and 1 (0.4%) 
an eighth recurrence. Table 1 presents the characteristics 
of the patients at diagnosis and initial treatment. Patients 
were mainly male (80%), Caucasian (97%), and former or 
current smokers (36 and 50%, respectively). Mean age at 
diagnosis was 69 years. The average intake of fruits and 
vegetables was evenly distributed between patients who had 
a recurrence of bladder cancer and those who had not (mean 
total fruit and vegetable intake for all patients 3,5 portions 
a day—283 and 275 g/day, respectively). No outliers were 
detected in fruit and vegetable intakes.
Table 2 presents HRs with corresponding 95% CI for pre- 
and post-diagnosis total fruit and vegetable intakes and time 
to first and time to multiple recurrences of bladder cancer. 
The sum of total fruit and vegetable intake before diagnosis 
did not affect the development of a first recurrence of bladder 
cancer (HR 1.07; 95% CI 0.78–1.47, p = 0.66) nor multiple 
recurrences (HR 1.02; 95% CI 0.90–1.15, p = 0.78). Total 
vegetable intake was not associated with a first recurrence 
or bladder cancer (HR 1.02, 95% CI 0.74–1.41, p = 0.88)—
similar results were found for the association with multiple 
recurrences (HR 0.97; 95% CI 0.86–1.11, p = 0.69). Total 
fruit intake before diagnosis was not associated with a first 
recurrence of bladder cancer (HR 0.85; 95% CI 0.63–1.14, 
p = 0.29). Results for total fruit intake and multiple recur-
rences indicated also no association with multiple recur-
rences (HR 1.05; 95% CI 0.91–1.20).
Table 3 presents the results for the remaining 389 NMIBC 
patients on total fruit and vegetable intake after diagnosis—
no associations were observed between the sum of total fruit 
and vegetable intake and a first recurrence (HR 0.65; 95% 
CI 0.42–1.01, p = 0.06) or multiple recurrences of bladder 
cancer (HR 1.00; 95% CI 0.85–1.18, p = 1.00). Total vegeta-
ble intake after diagnosis did not affect a first bladder cancer 
recurrence (HR 0.77; 95% CI 0.50–1.18, p = 0.23) nor multi-
ple recurrences (HR 0.96; 95% CI 0.74–1.09, p = 0.61). Post-
diagnosis intakes of total fruit were also not related to blad-
der cancer recurrence (HR 0.65; 95% CI 0.44–1.00, p = 0.05 
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for a first recurrence and HR 1.02; 0.87–1.20, p = 0.79 for 
multiple recurrences). In addition, results of the Cox pro-
portional hazard models predicting the development of a 
first and multiple recurrences of bladder cancer, based on 
subgroups of fruits and vegetables and vitamin supplement 
use, can be found in the online supplementary file (Tables 
S1–S12). Analyses on the consumption of subgroups of 
fruits and vegetables and vitamin supplement use showed no 
association with developing a recurrence of bladder cancer.
Discussion
This is the first study to investigate the role of fruit and vege-
table intakes before and after diagnosis and the recurrence of 
NMIBC. No evidence of an association was found between 
intakes of fruits and vegetables and bladder cancer recur-
rence in this prospective cohort study. It seems plausible, 
however, that substances in fruit and vegetables including 
minerals, phytochemicals, and antioxidant nutrients could 
protect against the development of cancer by reducing oxi-
dative stress and DNA damage caused by free radicals. 
Furthermore, it has been suggested that substances in fruit 
and vegetables could affect pathways involved in inflam-
mation and cell proliferation and apoptosis. More specifi-
cally, when glucosinolates found in cruciferous vegetables 
are broken down to form biologically active compounds 
including isothiocyanates and indoles, they have shown to 
inhibit the development of bladder cancer in mice and rats. 
Considering the low levels of antioxidants in patients with 
bladder cancer [4], it is conceivable that higher intakes of 
fruits and vegetables might result in an improved bladder 
cancer prognosis as well. An explanation for the lack of an 
association between fruit and vegetable intake and bladder 
cancer recurrence could be the difficulty to pinpoint the 
effect of one food group like fruits and vegetables given 
such a convoluted situation. Our diet consists of many dif-
ferent food items comprising many different nutrients, all 
working together at the same time. It seems plausible that 
any preventive effect may result from a combination of influ-
ences on pathways involved in the development of bladder 
cancer. Another explanation could be that tumor recurrence 
is more influenced by field cancerisation and tumor biology 
than beneficial bioactive compounds in fruit and vegetables 
[14, 15].
It is inevitable that usual fruit and vegetable intakes were 
not measured without error—recall bias and measurement 
errors in dietary intake cannot be excluded and are a com-
mon limitation of epidemiological studies. Sample sizes per 
average use category for subgroups of fruits and vegetables 
were small, especially in the post-diagnosis intake analyses. 
It is reasonable to assume that these small sample sizes have 
resulted in limited statistical power to examine associations 
between subgroups of fruits and vegetables and recurrence 
accurately. Finally, FFQs may be a source of error due to 
inadequate food composition information, a limited food list, 
Table 1  Patient characteristics at diagnosis for 728 NMIBC patients 
treated with transurethral resection of a primary bladder tumor
where the data contain missing values the percentages do not add up 
to 100%
 Number at risk (%)
Sex
 Male 584 (80%)
 Female 144 (20%)
Age at diagnosis (years)
 < 45 15 (2%)
 45–64 211 (29%)
 65–84 461 (63%)
 ≥ 85 41 (6%)
Smoking status
 Current smokers 366 (50%)
 Former smokers 263 (36%)
 Never smokers 99 (14%)
Alcohol consumption
 Drinkers 545 (75%)
 Non-drinkers 183 (25%)
Educational level
 High 76 (10%)
 Middle 106 (15%)
 None/low 165 (23%)
BCG intravesical immunotherapy
 Yes 112 (15%)
 No 281 (39%)
Mitomycin C intravesical chemotherapy
 Yes 342 (47%)
 No 72 (10%)
Tumor stage
 pTa 486 (67%)
 pT1 236 (32%)
 pTis 6 (1%)
Tumor grade
 1 214 (29%)
 2 263 (36%)
 3 251 (35%)
Size largest tumor (cm)
 < 3 460 (63%)
 ≥ 3 268 (37%)
Tumors multiplicity
 1 432 (59%)
 > 1 296 (41%)
No of recurrences over 5 years
 0 487 (67%)
 1 157 (22%)
 > 1 84 (11%)
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reporting average intake over a long period of time, under- or 
over-reporting of intake, and social desirability bias. Hence, 
the null results of this study could indicate that the use of 
FFQs may not be adequate to detect associations of total 
fruit and vegetable intake with bladder cancer recurrence, 
even if a relationship exists.
Conclusion
In this prospective cohort study, a lack of a protective asso-
ciation between the intake of fruit and vegetables and the 
risk of developing bladder cancer recurrence was demon-
strated. To this extend, no recommendations to increase the 
amount of fruits and vegetables after a diagnosis of NMIBC 
to prevent bladder cancer recurrence can be provided.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
Table 2  Hazard ratios (HR) and 95% confidence intervals (95% CI) for Cox proportional hazard models predicting recurrence of bladder cancer, 
based on total fruit, total vegetable, and total fruit + vegetable intake over the year before diagnosis, in 728 NMIBC patients
a Model 1 is unadjusted
b Model 2 is adjusted for age, sex, and smoking status
c Model 3 is adjusted for age, sex, smoking status, tumor stage, grade, size, and multiplicity (and additionally adjusted for re-resection of a blad-
der tumor (second transurethral resection) in the time to multiple recurrences analysis)
n Events Model  1a Model  2b Model  3c p for trend
HR (95% CI) p value HR (95% CI) p value HR (95% CI) p value
Time to first recurrence
 Total fruit + vegetables
  T1 225 69 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.68
  T2 251 82 1.07 (0.78–1.46) 0.69 1.08 (0.79–1.48) 0.63 1.09 (0.79–1.50) 0.60
  T3 252 90 1.15 (0.84–1.57) 0.38 1.14 (0.84–1.56) 0.40 1.07 (0.78–1.47) 0.66
 Total vegetables
  T1 216 67 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.86
  T2 259 84 0.98 (0.72–1.35) 0.91 1.00 (0.73–1.37) 1.00 0.97 (0.70–1.33) 0.84
  T3 253 90 1.11 (0.81–1.52) 0.52 1.11 (0.81–1.52) 0.53 1.02 (0.74–1.41) 0.88
 Total fruit
  T1 295 99 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.30
  T2 163 61 1.20 (0.87–1.66) 0.26 1.21 (0.88–1.67) 0.25 1.22 (0.89–1.69) 0.22
  T3 270 81 0.85 (0.63–1.14) 0.27 0.84 (0.63–1.13) 0.25 0.85 (0.63–1.14) 0.29
Time to multiple recurrences
 Total fruit + vegetables
  T1 225 102 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.76
  T2 251 140 1.03 (0.91–1.15) 0.66 1.01 (0.90–1.14) 0.87 1.00 (0.88–1.12) 0.94
  T3 252 149 1.03 (0.91–1.16) 0.64 1.02 (0.90–1.16) 0.73 1.02 (0.90–1.15) 0.78
 Total vegetables
  T1 216 105 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.77
  T2 259 130 0.99 (0.87–1.13) 0.89 0.99 (0.87–1.13) 0.85 0.95 (0.83–1.08) 0.44
  T3 253 156 1.00 (0.88–1.13) 0.94 1.00 (0.88–1.13) 0.94 0.97 (0.86–1.11) 0.69
 Total fruit
  T1 295 145 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.50
  T2 163 119 1.06 (0.94–1.19) 0.34 1.06 (0.94–1.19) 0.34 1.06 (0.94–1.21) 0.32
  T3 270 127 1.04 (0.92–1.17) 0.58 1.03 (0.89–1.18) 0.71 1.05 (0.91–1.20) 0.52
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  T2 144 54 0.93 (0.64–1.36) 0.72 0.94 (0.64–1.38) 0.75 0.84 (0.57–1.26) 0.40
  T3 112 39 0.83 (0.55–1.25) 0.37 0.86 (0.56–1.31) 0.48 0.77 (0.50–1.18) 0.23
 Total fruit
  T1 151 62 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.05
  T2 103 41 0.93 (0.63–1.39) 0.74 0.93 (0.62–1.38) 0.70 0.96 (0.63–1.44) 0.83
  T3 135 41 0.67 (0.45–0.99) 0.04 0.67 (0.45–0.99) 0.04 0.65 (0.44–1.00) 0.05
Time to multiple recurrences
 Total fruit + vegetables
  T1 138 89 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.96
  T2 136 82 0.94 (0.82–1.08) 0.41 0.96 (0.84–1.10) 0.57 0.98 (0.86–1.13) 0.79
  T3 115 50 0.96 (0.80–1.15) 0.66 0.97 (0.81–1.17) 0.77 1.00 (0.85–1.18) 1.00
 Total vegetables
  T1 133 77 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.58
  T2 144 91 0.96 (0.84–1.10) 0.55 0.97 (0.84–1.11) 0.66 0.97 (0.82–1.09) 0.63
  T3 112 53 0.94 (0.79–1.11) 0.44 0.95 (0.80–1.12) 0.53 0.96 (0.74–1.09) 0.61
 Total fruit
  T1 151 99 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 0.96
  T2 103 66 0.91 (0.80–1.04) 0.18 0.93 (0.81–1.06) 0.25 0.93 (0.81–1.06) 0.28
  T3 135 56 0.98 (0.83–1.16) 0.79 0.99 (0.84–1.18) 0.93 1.02 (0.87–1.20) 0.79
579Cancer Causes & Control (2018) 29:573–579 
1 3
 11. Stein JP, Grossfeld GD, Ginsberg DA, Esrig D, Freeman JA, 
Figueroa AJ et al (1998) Prognostic markers in bladder cancer: a 
contemporary review of the literature. J Urol 160(3 Pt 1):645–659
 12. Yan Y, Andriole GL, Humphrey PA, Kibel AS (2002) Patterns of 
multiple recurrences of superficial (Ta/T1) transitional cell carci-
noma of bladder and effects of clinicopathologic and biochemical 
factors. Cancer 95(6):1239–1246
 13. Ather MH, Nazim SM (2015) New and contemporary markers of 
prognosis in nonmuscle invasive urothelial cancer. Korean J Urol 
56(8):553–564
 14. Takahashi T, Habuchi T, Kakehi Y, Mitsumori K, Akao T, Terachi 
T et al (1998) Clonal and chronological genetic analysis of mul-
tifocal cancers of the bladder and upper urinary tract. Cancer Res 
58(24):5835–5841
 15. Simon R, Eltze E, Schäfer KL, Bürger H, Semjonow A, Hertle 
L et al (2001) Cytogenetic analysis of multifocal bladder cancer 
supports a monoclonal origin and intraepithelial spread of tumor 
cells. Cancer Res 61(1):355–362
